BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huo Z, Li C, Xu X, Ge F, Wang R, Wen Y, Peng H, Wu X, Liang H, Peng G, Li R, Huang D, Chen Y, Zhong R, Cheng B, Xiong S, Lin W, He J, Liang W. Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies. Oncoimmunology 2020;9:1848068. [PMID: 33299661 DOI: 10.1080/2162402X.2020.1848068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Wu Y, Huang J, Shan S, Mai M, Zhu J, Yang M, Shang D, Wu Z, Lan J, Zhong S, Wu M. Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies. Front Pharmacol 2021;12:748609. [PMID: 34867352 DOI: 10.3389/fphar.2021.748609] [Reference Citation Analysis]
2 Kaźmierczak O, Kozaczka A, Kolonko A, Kajor M, Pająk J, Chudek J. Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report. Am J Case Rep 2021;22:e933267. [PMID: 34695070 DOI: 10.12659/AJCR.933267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shen Y, Lian D, Shi K, Gao Y, Hu X, Yu K, Zhao Q, Feng C. Cancer Risk and Mutational Patterns Following Organ Transplantation. Front Cell Dev Biol 2022;10:956334. [DOI: 10.3389/fcell.2022.956334] [Reference Citation Analysis]
4 Huo Z, Ge F, Li C, Cheng H, Lu Y, Wang R, Wen Y, Yue K, Pan Z, Peng H, Wu X, Liang H, He J, Liang W. Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study. Sleep Med 2021;87:183-90. [PMID: 34627121 DOI: 10.1016/j.sleep.2021.06.044] [Reference Citation Analysis]
5 O'Connell KA, Schmults CD. Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:45-8. [PMID: 34855241 DOI: 10.1111/jdv.17407] [Reference Citation Analysis]
6 Meyer F, Weil-Verhoeven D, Prati C, Wendling D, Verhoeven F. Safety of biologic treatments in solid organ transplant recipients: A systematic review. Semin Arthritis Rheum 2021;51:1263-73. [PMID: 34507811 DOI: 10.1016/j.semarthrit.2021.08.013] [Reference Citation Analysis]
7 Koseki Y, Kamimura K, Tanaka Y, Ohkoshi-Yamada M, Zhou Q, Matsumoto Y, Mizusawa T, Sato H, Sakamaki A, Umezu H, Yokoyama J, Terai S. Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature. World J Clin Cases 2021; 9(30): 9182-9191 [PMID: 34786403 DOI: 10.12998/wjcc.v9.i30.9182] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cangemi M, Zanussi S, Rampazzo E, Bidoli E, Giunco S, Tedeschi R, Pratesi C, Martorelli D, Casarotto M, Martellotta F, Schioppa O, Serraino D, Steffan A, De Rossi A, Dolcetti R, Vaccher E. Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA. Front Oncol 2021;11:772348. [PMID: 34746013 DOI: 10.3389/fonc.2021.772348] [Reference Citation Analysis]